Examination of treatment utility and advantage of taking medicine in which acknowledgment function improvement in patient with schizophrenia with new antipsychotic is made main axis
Not Applicable
- Conditions
- schizophrenia
- Registration Number
- JPRN-UMIN000005025
- Lead Sponsor
- Department of Psychiatry,Kobe University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
In case of patients with diabetic mellitus is excluded because Olanzapine is contraindicated drug.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method